Preferred Label : Peroxisome biogenesis disorder 2a (zellweger);
Symbol : PBD2A;
CISMeF acronym : CG2; PBD2A;
Type : Phenotype, molecular basis known;
Included titles and symbols : Peroxisome biogenesis disorder, complementation group 2; CG2;
Description : The peroxisome biogenesis disorder (PBD) Zellweger syndrome (ZS) is an autosomal recessive
multiple congenital anomaly syndrome. Affected children present in the newborn period
with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial
anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia
punctata are present. Children with this condition do not show any significant development
and usually die in the first year of life (summary by Steinberg et al., 2006). For
a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger
syndrome, see 214100. Individuals with PBDs of complementation group 2 (CG2) have
mutations in the PEX5 gene. For information on the history of PBD complementation
groups, see 214100.;
Inheritance : Autosomal recessive, several forms;
Prefixed ID : #214110;
Origin ID : 214110;
UMLS CUI : C3550273;
Broader ORDO disease(s)
CISMeF manual mappings
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)